centogene
opens
testing
facility
düsseldorf
airport
centogene
expands
testing
solution
düsseldorf
airport
successfully
launching
test
facilities
frankfurt
hamburg
airport
company
pcr
tests
available
passengers
departing
arriving
düsseldorf
airport
well
general
public
expansion
testing
düsseldorf
airport
paves
way
towards
new
normal
communities
economies
cambridge
mass
rostock
germany
berlin
globe
newswire
centogene
nasdaq
cntg
company
focused
rare
diseases
transforms
clinical
genetic
data
actionable
information
patients
physicians
pharmaceutical
companies
announced
today
opening
new
testing
facility
düsseldorf
airport
centogene
also
provides
test
solution
detection
virus
düsseldorf
airport
addition
departing
travelers
need
valid
coronavirus
test
result
destination
well
arriving
passengers
düsseldorf
airport
general
public
düsseldorf
area
also
get
tested
test
facility
open
located
centrally
terminal
c
düsseldorf
airport
people
interested
taking
test
register
directly
test
facility
without
needing
appointment
conveniently
get
sample
taken
via
throat
swab
results
delivered
within
hours
centogene
secure
digital
platform
information
please
visit
https
new
testing
facility
düsseldorf
airport
build
experience
frankfurt
hamburg
airport
successfully
carried
hundreds
thousands
tests
since
june
demand
testing
remains
high
convinced
obligatory
quarantine
following
international
air
travel
massively
affect
global
travelling
turn
contributes
essentially
efficiency
economy
fact
without
alternative
option
corona
test
quarantine
obligation
tantamount
complete
shutdown
business
travels
kind
said
volkmar
weckesser
chief
information
officer
von
centogene
cooperation
düsseldorf
airport
brings
advantages
comprehensive
test
solution
placed
locally
therefore
readily
available
north
rhine
westphalia
efficiently
adding
containing
pandemic
broad
preventive
testing
option
enables
detection
breaking
chains
infections
ultimately
paves
way
new
convinced
expanding
existing
testing
capacities
opposed
getting
rid
testing
options
travelers
returning
risk
countries
october
onwards
dismantling
successfully
established
test
infrastructure
airports
reasonable
way
therefore
delighted
opening
new
test
center
düsseldorf
airport
data
obtained
testing
also
make
significant
contribution
reacting
current
infection
situation
targeted
appropriate
measures
lufthansa
centogene
continuously
expanding
capacities
cooperation
serves
benchmark
successful
test
solution
said
christina
foerster
lufthansa
group
customer
corporate
responsibility
board
member
centogene
test
facility
open
anybody
wants
get
tested
traveling
company
strongly
believes
complete
digitalization
connected
effective
way
deliver
tests
easy
handle
quickly
available
process
supported
innovative
digital
solution
allows
customer
easily
register
order
download
test
results
via
smartphone
computer
complete
testing
solution
centogene
test
molecular
diagnostic
test
performed
vitro
qualitative
detection
rna
oropharyngeal
samples
presymptomatic
patients
probands
according
recommended
testing
public
health
authority
guidelines
test
also
validated
centogene
cap
clia
iso
certified
analytical
laboratory
received
emergency
use
authorization
eua
united
states
food
drug
administration
fda
use
authorized
laboratories
samples
taken
medically
trained
personnel
using
dry
plastic
swab
oropharyngeal
swab
sampling
samples
brought
centogene
laboratory
testing
test
results
delivered
test
center
visitors
via
centogene
corona
test
portal
secure
digital
platform
following
stringent
data
privacy
measures
compliance
current
specifications
gdpr
german
data
protection
regulation
datenschutzgrundverordnung
health
insurance
portability
accountability
act
hipaa
portal
connected
corona
warn
app
please
also
visit
https
see
latest
testing
statistics
frankfurt
airport
information
centogene
centogene
engages
diagnosis
research
around
rare
diseases
transforming
clinical
genetic
data
actionable
information
patients
physicians
pharmaceutical
companies
goal
bring
rationality
treatment
decisions
accelerate
development
new
orphan
drugs
using
extensive
rare
disease
knowledge
including
epidemiological
clinical
data
well
innovative
biomarkers
centogene
developed
global
proprietary
rare
disease
platform
based
data
repository
approximately
billion
weighted
data
points
patients
representing
different
countries
march
company
platform
includes
epidemiologic
phenotypic
genetic
data
reflects
global
population
also
biobank
patients
blood
samples
centogene
believes
represents
platform
comprehensively
analyzes
data
improve
understanding
rare
hereditary
diseases
aid
identification
patients
improve
pharmaceutical
partners
ability
bring
orphan
drugs
market
march
company
collaborated
pharmaceutical
partners
covering
different
rare
diseases
important
notice
disclaimer
press
release
contains
statements
constitute
forward
looking
statements
term
defined
united
states
private
securities
litigation
reform
act
including
statements
express
company
opinions
expectations
beliefs
plans
objectives
assumptions
projections
regarding
future
events
future
results
contrast
statements
reflect
historical
facts
examples
include
discussion
strategies
financing
plans
growth
opportunities
market
growth
cases
identify
statements
terminology
anticipate
intend
believe
estimate
plan
seek
project
expect
may
would
could
negative
terms
similar
expressions
forward
looking
statements
based
management
current
beliefs
assumptions
information
currently
available
company
however
statements
guarantee
performance
place
undue
reliance
statements
statements
subject
many
risks
uncertainties
variable
circumstances
negative
worldwide
economic
conditions
ongoing
instability
volatility
worldwide
financial
markets
effects
pandemic
business
results
operations
possible
changes
current
proposed
legislation
regulations
governmental
policies
pressures
increasing
competition
consolidation
industry
expense
uncertainty
regulatory
approval
including
food
drug
administration
reliance
third
parties
collaboration
partners
including
ability
manage
growth
enter
new
client
relationships
dependency
rare
disease
industry
ability
manage
international
expansion
reliance
key
personnel
reliance
intellectual
property
protection
fluctuations
operating
results
due
effect
exchange
rates
factors
risks
uncertainties
may
cause
statements
inaccurate
readers
cautioned
place
undue
reliance
statements
many
risks
outside
company
control
could
cause
actual
results
differ
materially
thought
would
occur
statements
included
press
release
made
date
hereof
company
undertake
specifically
declines
obligation
update
statements
publicly
announce
results
revisions
statements
reflect
future
events
developments
except
required
law
information
please
refer
risk
factors
section
annual
report
year
ended
december
form
filed
sec
april
current
reports
documents
filed
securities
exchange
commission
sec
may
obtain
documents
visiting
edgar
sec
website
questions
tests
düsseldorf
airport
contact
phone
centogene
ben
legg
corporate
communications
fti
consulting
bridie
lawlor
